Hi All. I have today been to see Professor Quenby and feel even more at a loss as to what to do in future pregnancies.
Basically, the NK cells research trial is on hold as there is no funding, but she would keep me on the list if they get further funding. She then went on to outline some research published this year which concluded that aspirin, or a combination of aspirin and heparin, did not increase the live birth rate in women who have had 3 or more miscarriages and have no blood clotting issues. In fact, those women in the study taking the placebo drugs had the highest live birth rate! The upshot is that she no longer recommends people take aspirin and/or heparin unless they have clotting issues.
The study she is currently running is called Promise which is a progesterone study. Basically women with 3+ miscarriages are given either progesterone or a placebo and then basically see what happens.
This leaves me in a dilemna - do I:
a) Join the research trial and get either the progesterone or the placebo. This means not taking ANY other drugs at all (aspirin, 5mg folic acid etc)
b) Not join the trial and take cyclogest (progesterone) which my GP prescribes me anyway. This way I know I am getting the "real" drug and not the placebo.
c) Have another go at aspirin, heparin and cyclogest. If this fails again then I will know that in theory, none of these drugs work for me.
DH was with me, and I know as she said aspirin and heparin aren't proven to help, he would rather I didn't take them, but I don't want to risk getting the placebo drug and basically going into another pregnancy doing nothing, as we already know that doesn't work!
I know it is selfish not to do the trial as I do appreciate the need for it to be done for the greater good, but I can't help being selfish as I don't want another miscarriage and I feel like doing something (aspirin, heparin, progesterone) is better than nothing (placebo and nothing else).
Any advice ladies?
ps. Here is the study disproving aspirin and heparin in case you are interested.
https://www.nejm.org/doi/full/10.1056/NEJMoa1000641